




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Atrial Fibrillation/Supraventricular Arrhythmias</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=9d928ff7-0a69-4d5c-8ae4-9a5be446fc6b</link>
        <description>Clinical Topic Feed: Atrial Fibrillation/Supraventricular Arrhythmias</description>
        <language>en</language>

        

                <item>
                    <title>AFib Ablation Approaches Differ by Hospital Teaching Status | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/15/14/32/AFib-Ablation-Approaches-Differ-by-Hospital-Teaching-Status</link>                    <description>Procedural approaches for atrial fibrillation (AFib) ablation differ by hospital teaching status; however, overall complication rates are similar, according to a recent study published in JAHA.</description>
                    <pubdate>1778884980000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Ivabradine vs. Propranolol For POTS; Testosterone Prescribing Trends</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/Ivabradine-vs-Propranolol</link>                    <description>Both ivabradine and propranolol reduced tachycardia and symptoms of postural orthostatic tachycardia syndrome (POTS), compared with placebo, based on findings from a randomized, double-blind crossover trial published in JACC and JACC: Advances.</description>
                    <pubdate>1778688060000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>&#226;€&#175;Eagle&#226;€™s Eye View: Can Rhythm Control Improve Tricuspid Regurgitation? </title>
<link>/Latest-in-Cardiology/Articles/2026/05/12/15/21/eagles-eye-view-13may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle examines the role of rhythm control in improving moderate-to-severe and severe secondary tricuspid valve regurgitation.</description>
                    <pubdate>1778679000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Journals Science at ESC Heart Failure Congress 2026</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/JACC-Journals-Science-at-ESC-Heart-Failure-Congress-2026</link>                    <description>Findings from several studies presented at ESC Heart Failure Congress 2026 in Barcelona, Spain, were simultaneously published in JACC and JACC: Heart Failure, covering topics like arrhythmic burden in cardiac amyloidosis (CA), stroke and bleeding risk in CA...</description>
                    <pubdate>1778607960000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>New in Clinical Guidance | Key Points From the 2026 Advanced Training Statement on CCEP</title>
<link>/Latest-in-Cardiology/Articles/2026/06/01/01/New-in-Clinical-Guidance-2026-ATS-CCEP</link>                    <description>The following are key points from the 2026 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (Revision of the 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology)...</description>
                    <pubdate>1778156160000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Rhythm Control May Improve Moderate-Severe/Severe Secondary TR</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/04/11/24/Rhythm-Control-May-Improve</link>                    <description>Successful rhythm control of atrial fibrillation (AFib) was associated with improved secondary tricuspid regurgitation (STR) in patients with moderate-severe or severe STR, according to research published April 23 in JACC: Cardiovascular Imaging.</description>
                    <pubdate>1778094060000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>&#226;€&#175;Eagle&#226;€™s Eye View: PCI Vs. CABG In Patients With Unprotected Left Main CAD: NOBLE Study </title>
<link>/Latest-in-Cardiology/Articles/2026/05/06/13/43/eagles-eye-view-06may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at the NOBLE trial evaluating whether percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is best for patients with unprotected left main coronary artery disease (CAD).</description>
                    <pubdate>1778075040000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Continuing vs. Switching DOAC Therapy in AFib Patients With Breakthrough Stroke</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/04/11/24/Continuing-vs-Switching-DOAC-Therapy</link>                    <description>In patients with atrial fibrillation (AFib) experiencing a breakthrough ischemic stroke while on a direct oral anticoagulant (DOAC) regimen, switching to a different DOAC was noninferior to continuing the same DOAC, according to a study published April 28 in JAMA Network Open.</description>
                    <pubdate>1778074320000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>AVANT-GUARD: Pulsed Field Ablation as First-Line Therapy For Patients With Persistent AFib</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/04/11/24/AVANT-GUARD</link>                    <description>The likelihood of recurrence of atrial arrhythmia in patients with persistent atrial fibrillation (AFib) was lower for those who received pulsed field ablation (PFA) as first-line therapy when compared to those who first tried antiarrhythmic drug (AAD) therapy, according to results from the AVANT-GUARD trial published April 25 in NEJM.</description>
                    <pubdate>1777994460000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>A Patient With a Misdiagnosed Psychiatric Disorder (Part 1)</title>
<link>/Education-and-Meetings/Patient-Case-Quizzes/2026/04/23/10/13/A-Patient-With-a-Misdiagnosed-Psychiatric-Disorder-1</link>                    <description>A 45-year-old woman who lives alone in a rural area experiences sudden onset of palpitations associated with dyspnea, profuse sweating, paresthesia in both hands, and a rapid pounding sensation in her neck after an argument with a neighbor.</description>
                    <pubdate>1777552740000</pubdate>
                    <category>Educational Activities</category>
                </item>

    </channel>
</rss>